News

Reinforcing its Northern Ireland’s position in the wider life sciences sector, the dual expansion represents a total investment of £13.7m with some financial assistance from Invest Northern Ireland.

LAUTECH Public Relations Unit head Ayodele Adeyemo was quoted by Osun Defender as saying that the license was granted by the PCN Acting Registrar, GO Abumere and authorizes

The pill was earlier available to women aged 17 years and more, only on submitting their age proof at the pharmacy counters. The US Department of Justice is

Acquisition of the rights, which is still subject to certain closing conditions, will enable the firm to develop Synacthen and Synacthen Depot in the US as well as

Stating improved product’s indication, the new label provides dosing guidelines for different categories of patients, including those weighing over 100kg. The new indication states, "Acetadote is an antidote

AxION iQT system provides greater quantitative capabilities compared to a triple quad and can identify 500 compounds per second similar to a quadrupole time-of-flight (Q-TOF). The device has

As part of a collaboration between both the parties, which was signed in 2010, Xenon will now be responsible for all future development and commercialization of XEN701. XEN701

Following to completion of review of the Trokendi XR new drug application as revised in December 2012, the regulator approved the product for use as recommended in the

The Protein Purification Facility will leverage the cGMP compatible stable, non-lytic protein expression platform for expression of complex and challenging proteins, including Fab fragments and other proteins. ExpreS2ion